ARTICLE | Clinical News
Ceplene histamine dihydrochloride: Started Phase II trial
December 24, 2001 8:00 AM UTC
Maxim Pharmaceuticals Inc. (MAXM; SSE:MAXM), San Diego, Calif. Product: Ceplene (formerly Maxamine) histamine dihydrochloride Business: Infectious diseases Therapeutic category: Immune stimulation, ...